Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2004
05/26/2004CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
05/25/2004US6740754 Process to produce oxazolidinones
05/25/2004US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/25/2004US6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
05/25/2004US6740657 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
05/25/2004US6740309 Delivery of compounds for the treatment of migraine through an inhalation route
05/25/2004US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products
05/25/2004US6740307 Delivery of β-blockers through an inhalation route
05/25/2004US6740306 Imidazotriazinone-containing compositions for nasal administration
05/25/2004CA2302058C A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one
05/21/2004WO2004042002A2 Compounds for modulating rna interference
05/21/2004WO2004041827A2 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-α] IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE AND THEIR USE AS INHIBITORS UPON THE INTERACTION OF CAMS AND LEUKO INTEGRINS
05/21/2004WO2004041826A1 Imidazopyrazinones and imidazotriazinones derivates as gaba-a receptor anxiolytic
05/21/2004WO2004041825A1 5-alkyl-7-aminotriazolopyrimidines, methods and intermediary products necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms
05/21/2004WO2004041824A2 6-(2-halogenphenyl)-triazolopyrimidines derivatives and their use as fungicide
05/21/2004WO2004041823A1 Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
05/21/2004WO2004041822A1 Pyrimido[4,5-d]pyrimidine derivatives with anticancer activity
05/21/2004WO2004041821A1 Pyrimido compounds having antiproliferative activity (ii)
05/21/2004WO2004041273A1 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3-SULFONYL]-PYRROLIDINE-2-CARBOXYLIC ACID AMIDE AS ANTI-INFLAMMATORY AGENTS
05/21/2004WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
05/21/2004WO2004041209A2 Transcription factor modulating compounds and methods of use thereof
05/21/2004WO2004041162A2 Inhibitors of akt activity
05/21/2004WO2004018473A3 Azapurine derivatives
05/21/2004WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
05/21/2004WO2003101455A3 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
05/21/2004WO2002090361A8 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
05/21/2004WO2002083686B1 Processes for large scale production of tetrapyrroles
05/21/2004CA2504827A1 6-(2-halogenphenyl)-triazolopyrimidines derivatives and their use as fungicide
05/21/2004CA2504219A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-.alpha.] imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leuko integrins
05/21/2004CA2504192A1 5-alkyl-7-aminotriazolopyrimidines, methods and intermediary products necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms
05/21/2004CA2504131A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-alpha]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
05/21/2004CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
05/21/2004CA2502477A1 Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
05/21/2004CA2502182A1 Pyrimido[4,5-d]pyrimidine derivatives with anticancer activity
05/21/2004CA2502180A1 Pyrimido compounds having antiproliferative activity (ii)
05/20/2004US20040097758 Halogen-fluorine exchange or addition of HF to a C-C multiple bond in with a fluorination agent in the presence of an HF adduct of a monocyclic or bicyclic amine containing at least two nitrogen atoms at least one of which in in the ring
05/20/2004US20040097736 Can induce biosynthesis of various cytokines and are useful in treatment of a variety of conditions including viral diseases and neoplastic diseases
05/20/2004US20040097725 Charge transport compositions and electronic devices made with such compositions
05/20/2004US20040097723 For diagnosis/treatment of diseases; photodynamics; tomography; for use in magnetic resonance imaging
05/20/2004US20040097545 Quinolinone derivatives
05/20/2004US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
05/20/2004US20040097535 Suitable for disinfection, deodorisation, and for the general and antimicrobial treatment of the skin and mucosa, and integumentary appendages (hair), especially for the disinfection of hands and wounds
05/20/2004US20040097526 Using triazolo(4,5-d)pyrimidine derivatives or a pharmaceutically acceptable salt or prodrug, in manufacture of a medicament for therapy or prevention of a disorder in which blocking of purine receptors may be beneficial
05/20/2004US20040097522 For controlling undesirable microorganisms and animal pests
05/20/2004US20040097506 Pyrimidine derivatives for inhibition of cell proliferation
05/20/2004US20040097505 Reacting benzamide derivative with haloketone compound to form imidazotriazine compound
05/20/2004US20040097501 Triazole compounds useful as protein kinase inhibitors
05/20/2004US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders
05/20/2004US20040097490 Novel heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as B-lactamase inhibitors and antibacterials
05/20/2004US20040096860 For engines/machines; comprises complexing agents; chemical linkers
05/20/2004US20040096787 Color photography
05/20/2004US20040094818 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device
05/19/2004EP1420022A1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
05/19/2004EP1419162A1 Substituted-aryl 7-aza 2.2.1]bicycloheptanes for the treatment of disease
05/19/2004EP1419161A1 Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease
05/19/2004EP1419160A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
05/19/2004EP1419159A1 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
05/19/2004EP1322649B1 Process for the preparation of 2-alkoxy-6-trifluoromethyl-n-([1,2,4]triazolo[1,5-c]pyrimidin-2-yl)benzenesulfonamides
05/19/2004EP1289987B1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo- 3.2.2]nonane derivatives, preparation and therapeutic use thereof
05/19/2004EP1220855B1 Anhydrous salt
05/19/2004EP1025102B1 Bicyclic kinase inhibitors
05/19/2004EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/19/2004EP0942722B1 Tetrahydro-beta-carboline compounds
05/19/2004EP0862624B1 Water soluble cross-linking agents
05/19/2004EP0717736B1 Phosphorus derivatives to treat aids
05/19/2004DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
05/19/2004CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase
05/19/2004CN1498218A Imidazo-pyrimidine derivatives as ligands for GABA receptors
05/19/2004CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
05/19/2004CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them
05/19/2004CN1496983A Method for preparing oxazolidone amine
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/19/2004CN1150195C Bicyclic nitrogen heterocycles
05/19/2004CN1150166C CB2 receptor agonist compounds
05/18/2004US6737533 Pigmented vitreous material
05/18/2004US6737042 Delivery of drug esters through an inhalation route
05/13/2004WO2004040003A2 Nucleotide-binding protein-directed probes and methods of their synthesis and use
05/13/2004WO2004039815A2 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases
05/13/2004WO2004039809A1 Novel quinoxaline derivatives
05/13/2004WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
05/13/2004WO2004039774A2 Mitotic kinesin inhibitors
05/13/2004WO2004039318A2 Anti-infective biaryl compounds
05/13/2004WO2004024078A3 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
05/13/2004WO2004009542A3 Process for preparing certain pyrrolotriazine compounds
05/13/2004WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
05/13/2004US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
05/13/2004US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists
05/13/2004US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration
05/13/2004US20040092737 Benzopiperidine derivatives
05/13/2004US20040092736 Collections of compounds
05/13/2004US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions
05/13/2004US20040092627 Warp-free pigment compositons comprising diaryldiketopyrrolo[3,4-c]pyrroles
05/13/2004US20040092559 Bicyclic modulators of androgen receptor function
05/13/2004US20040092537 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy
05/13/2004US20040092533 Central nervous system disorders; anxiolytic agents; anticonvulsants; cognition activators; side effect reduction
05/13/2004US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
05/13/2004US20040092525 Pirazino(aza)indole derivatives
05/13/2004US20040092509 Controlling dosage times
05/13/2004US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
05/13/2004US20040091812 Lithographic printing plate precursors imageable elements; form dry films at ambient temperature